Frederic Sottilini

Frédéric has an engineering background from ENST in Paris and an MBA from EM Lyon. After beginning his career at Siemens in Nuclear Medicine and Radiotherapy, he held various international management positions over 20 years and has built solid experience in launching new medical technologies. As Business Manager at EDAP TMS, he led the launch of Ablatherm®, the first device using therapeutic ultrasound for the treatment of prostate cancer. He was also CEO of Accuray Europe and launched the first CyberKnife robotic radiosurgery systems in Europe. Before joining Carthera®, he was the Director of the Strategy and Business Development of the Healthcare Incubator at Philips in Eindhoven.